Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history
Pfizer has rejected allegations made by rival Moderna that its Covid-19 vaccine is a copy, accusing the Boston biotech company of rewriting history to lay...
Pfizer Inc
-
-
We’re increasing price targets on 3 of our stocks, including 2 crushing the boarder market
Following our price target changes on eight Club holdings last month, we’re updating three more Tuesday to reflect their recent quarterly earnings reports and outlooks....
-
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine...
-
Stocks making the biggest moves midday: Uber, Abiomed, Peloton, Carvana, Molson Coors and more
A traveller waits for an Uber rider at Midway International Airport on May 09, 2022 in Chicago, Illinois. Uber plans to cut spending and hiring...
-
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company’s data shows
Pfizer’s vaccine against respiratory syncytial virus, or RSV, is highly effective at protecting newborns when the shot is given to the mothers late in their...
-
FDA says two studies showing omicron boosters weren’t much better than old Covid shots were too small to come to any conclusions
The Food and Drug Administration said two studies this week showing that the new omicron boosters weren’t that much better than the old shots were...
-
Stocks making the biggest moves midday: Snap, American Express, Verizon, Twitter and more
Check out the companies making headlines in midday trading. Snap — Shares of the Snapchat parent company cratered 28.1% after it missed revenue estimates and...
-
Semafor debuts in a tough media environment, with an aim toward decluttering the news
Ben Smith, left, and Justin Smith Source: Semafor Semafor, a new digital media company with a focus on global news for college-educated readers, debuted Tuesday...
-
Omicron BA.5 is declining in the U.S. as emerging variants gain ground, CDC data shows
The U.S. faces at least seven different versions of Covid-19 omicron as the nation heads into winter when health officials are expecting another wave of...
-
Pfizer says omicron shots substantially boosted antibodies against BA.5 subvariant in early human data
Jakub Porzycki | NurPhoto | Getty Images Pfizer and its German partner BioNTech on Thursday said their new omicron boosters substantially increased protective antibodies against...
-
Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old
Following CDC approval for vaccination of children aged 6 months to 5 years, 4 year-old Eleanor Kahn sits with her father Alex, as nurse Jillian...
-
New omicron boosters are now available, but it’s unclear how effective they will be
The U.S. authorized the first major makeover of the Covid-19 vaccines this week in an effort to stem an expected tide of infections and hospitalizations...